Townsquare Capital LLC Coherus Bio Sciences, Inc. Transaction History

Townsquare Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$10.92 - $16.41 $385,257 - $578,944	-35,280 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$15.81 - $18.99 $126,385 - $151,806	7,994 Added 29.3%	35,280 $563,000
Q3 2021 Nov 15, 2021	BUY	$12.68 - $17.79 $159,172 - $223,317	12,553 Added 85.2%	27,286 $438,000
Q2 2021 Aug 16, 2021	BUY	$12.95 - $15.41 $190,792 - $227,035	14,733 New	14,733 $201,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $84.7M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Townsquare Capital LLC with notifications on news.